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Abstract The therapeutic potential of adult stem
cells may become a relevant option in clinical care in
the future. In hand and plastic surgery, cell therapy
might be used to enhance nerve regeneration and help
surgeons and clinicians to repair debilitating nerve
injuries. Adipose-derived stem cells (ASCs) are found
in abundant quantities and can be harvested with a low
morbidity. In order to define the optimal fat harvest
location and detect any potential differences in ASC
proliferation properties, we compared biopsies from
different anatomical sites (inguinal, flank, pericardiac,
omentum, neck) in Sprague–Dawley rats. ASCs were
expanded from each biopsy and a proliferation assay
using different mitogenic factors, basic fibroblast
growth factor (bFGF) and platelet-derived growth
factor (PDGF) was performed. Our results show that
when compared with the pericardiac region, cells
isolated from the inguinal, flank, omental and neck
regions grow significantly better in growth medium
alone. bFGF significantly enhanced the growth rate of
ASCs isolated from all regions except the omentum.
PDGF had minimal effect on ASC proliferation rate
but increases the growth of ASCs from the neck
region. Analysis of all the data suggests that ASCs
from the neck region may be the ideal stem cell
sources for tissue engineering approaches for the
regeneration of nervous tissue.
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Introduction
Bone marrow stromal cells are known as multipotent
stem cells under specific conditions (Prockop 1997)
and are an attractive cell source for tissue engineering
(Dezawa et al. 2001). However, the isolation of these
stem cells is associated with a considerable morbidity.
In general, the site of biopsy should be easily
accessible, show minimal donor site morbidity and
have the option of repeated biopsies if needed.
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Adipose-derived stem cells (ASCs) are found in
abundant quantities, have high proliferation rates, can
be harvested by minimally invasive procedures and
are multi-potent cells capable of becoming bone,
cartilage, muscle, endovascular, neuronal, and other
cells (Liang et al. 2011; Strem et al. 2005; Taha and
Hedayati 2010; Witkowska-Zimny and Walenko
2011). The characteristics of ASCs are closely similar
to those of other types of mesenchymal stem cells
(MSCs) (Dhanasekaran et al. 2012; Zuk et al. 2002).
They have been successfully tested in preclinical
models, which opens a wide field of clinical applica-
tions (Wu et al. 2011; Zhang et al. 2012). Remarkable
is that the frequency of ASCs in adipose tissue far
exceeds the MSCs frequency in bone marrow, which is
only 0.01–0.001 % (Strem et al. 2005). This makes
ASCs a promising alternative source of MSCs for
tissue engineering (Strioga et al. 2012).
The harvested fat sample should have a high density
of expandable ASCs with minimal contamination of
fascial tissues. Knowing the ideal biopsy location
might allow the surgeon to take a smaller biopsy
without restricting the proliferation rate of ASCs.
Recently we showed that human ASCs isolated
from the superficial layer of abdominal fat tissue
proliferate significantly faster than those from the
deeper layer (Kalbermatten et al. 2011). In the
superficial and deep layer, pluripotent stem cell
markers oct4, nanog and also the stro-1 cell surface
antigen were expressed (Kalbermatten et al. 2011).
Other factors such as the type of surgical procedure
may also affect growth characteristics and the yield of
ASCs. Oedayrajsingh-Varma et al. (2006) suggested
that adipose tissue derived from both abdomen and
hips harvested by resection or tumescent liposuction
can be used for tissue-engineering purposes. It has also
been shown that adipose tissue harvested from the
breasts, because of presence of glandular cells, may
lead to extensive variations in cell counts. Moreover it
cannot be excluded that differentiated glandular cells
affect ASC proliferation and differentiation (Oed-
ayrajsingh-Varma et al. 2006).
In this research we hypothesized that harvest
location is a key factor for the quality of ASCs for
nerve regeneration. In order to define the optimal
adipose tissue from which to harvest the ASCs, we
compared fat tissue from different origins and eval-
uated the expansion potential with different mitogenic
factors.
Materials and methods
Harvest and culture of ASCs
All studies were approved by the local veterinary
physician. ASCs were harvested as described previ-
ously by our group (di Summa et al. 2010). One gram of
adipose tissue was harvested from the most represen-
tative sources according to the literature (Aguena et al.
2012; Bayes-Genis et al. 2012; Mohammadi et al. 2012;
Padoin et al. 2008; Yuan et al. 2010) (inguinal, flank,
pericardiac, neck and omentum) in four male Sprague–
Dawley (SD) rats aged 8 weeks weighing approxi-
mately 250 g. SD rats were selected because they are
widely used in the field of tissue engineering and
peripheral nerve repair (di Summa et al. 2010). The
adipose tissue was carefully dissected, minced by using
a sterile razor blade and placed for 2 h at 37 C in 15 ml
Hank’s balanced salt solution (HBSS) containing 0.2 %
(w/v) collagenase type 1 and 20 ll penicillin/strepto-
mycin for enzymatic digestion. Next, the enzyme was
neutralized by adding growth medium (GM) containing
Modified Eagle’s Medium (a-MEM; Invitrogen, Pais-
ley, UK), 10 % (v/v) fetal bovine serum (FBS) and 1 %
(v/v) penicillin/streptomycin (Gibco, Grand Island,
NY, USA). The samples were centrifuged at 1,200g for
5 min and the resultant stromal cell pellet was resus-
pended in GM. Subsequently, the solution was passed
through a 70-lm filter to remove remaining undissoci-
ated tissue, centrifuged at 1,000g for 5 min and the
pellet resuspended in GM. The ASCs were propagated
and plated in a 75 cm2 tissue culture flask. Cells were
incubated at 37 C with 5 % CO2 and were maintained
at sub-confluent levels with passage by trypsin/EDTA
(Invitrogen, UK) when required.
Cell proliferation
The proliferation of the ASCs isolated from different
origins were assessed for 96 h using the CellTiter 96
Aqueous non-radioactive cell proliferation assay (Pro-
mega, Madison, WI, USA). At passage 2, 1 9 103 cells
were plated in a 96-well plate using either 200 ll of GM
alone, or supplemented with basic fibroblast growth
factor bFGF (10 ng/ml) or platelet-derived growth
factor PDGF (5 ng/ml). At the time of seeding the
signal was assessed for all sources and normalized. At
regular intervals (24, 48, 72, 96 h), 20 ll of Cell Titer
96 Aqueous Assay Reagents (Promega, USA) were
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added and incubated for 4 h at 37 C and 5 % CO2. The
absorbance was recorded at 490 nm using a spectro-
photometric plate reader and measurements were cal-
culated by subtracting the average control absorbance
(medium only) from the average cell absorbance. The
different patterns of proliferation among different time-
points were performed in the same groups along the 96 h
and compared with the 24 h time-point.
Based on the fact that the number of cells is
proportional to the absorbance recorded by the Cell
Titer Assay we were able to calculate population
doubling (PD) times using exponential curve fitting
software (Mohamet et al. 2010).
Immunocytochemistry
ASCs (2 9 104 cells) at passage 2 were plated on Lab-
Tek 4-well chamber slides (Thermo Scientific, Nunc,
Fisher Scientific AG, Wohlen, Switzerland), cultured
for 3 days until confluence of 60 % was reached,
washed with phosphate buffered saline (PBS) and
fixed for 20 min in 4 % paraformaldehyde. The cells
were washed for 2 min in PBS and blocked for 1 h in
immunofluorescence blocking buffer (IBB) contain-
ing 1 % bovine serum albumin (BSA, Invitrogen,
15561-020), 19 PBS and 0.1 % Triton X-100 (Sigma-
Aldrich, Munich, Germany). After washing three
times with PBS the cells were subsequently incubated
over night at 4 in PBS with 0.1 % (v/v) Triton
containing the following antibodies: S100 (Z0311,
Dako, Baar, Switzerland) (1:500), Nestin (MAB353,
Chemicon, Temecula, CA, USA) (1:200) and GFAP
(Neomarkers Ab-1, Clone GA-5, Lab Vision/Thermo
Fisher Scientific) (1:400). The cells were washed three
times with PBS and incubated for 40 min under light
protection in PBS containing Alexa Fluor 488 goat
anti-rabbit IgG (Invitrogen, A-11008) (1:500), Alexa
Fluor 594 goat anti-mouse IgG (Invitrogen,
A-11005) (1:500) or Alexa Fluor 488 goat anti-
mouse IgG (Invitrogen, A-11001) (1:500). Cell nuclei
were stained with 40,6-diamidino-2-phenylindole
(Sigma, D9542) (1:500).
Statistical analysis
Data are presented as mean ± SEM from four
animals. All experimental samples were conducted
in triplicate and the four rats were used as independent
biological replicates. Where appropriate t-tests or
one-way ANOVA with Bonferoni post hoc test for
multiple comparisons were used to determine the
statistically significant differences between groups.
The following convention was used in the figures:
*p \ 0.05; **p \ 0.01; ***p \ 0.0001.
Results
One gram of adipose tissue biopsy was harvested from
different origins (inguinal, flank, pericardiac, neck and
omentum) (Fig. 1) in rats. After enzymatic digestion
and centrifugation the stromal cell fraction was
isolated from mature adipocytes and plated in a
75-cm2 flask. After 3 weeks in culture, upon reaching
confluence, cells were trypsinized and counted. ASCs
were plastic-adherent and expressed basal levels of
S100 with a high expression in ASCs from the neck
and flank regions (Fig. 2b–f). A small fraction of cells
was found to be nestin positive (Fig. 2a). Undifferen-
tiated ASCs were negative for expression of GFAP
(data not shown). We compared the proliferation of
the ASCs (passage 2) isolated from over a 96 h period.
Within 96 h the cells were still proliferating and
importantly did not show a saturating signal in the
assay. The cells were incubated with either GM alone
or GM with bFGF or PDGF.
As shown in Fig. 3a, ASCs isolated from the
inguinal, flank and omental region grow significantly
better after 96 h in GM alone versus after 24 h. ASCs
from the neck region grow least in GM. However,
bFGF significantly enhanced the growth rate of all
types within 48 h, with the greatest effect on neck
ASCs. On the other hand, ASCs from the pericardiac
and omental regions responded least (Fig. 3b). Similar
results were observed with PDGF; PDGF speeded the
proliferation of ASCs from the neck region signifi-
cantly better within 72 h but had no effect on ASCs
from the pericardiac region (Fig. 3c). From prolifer-
ation assays, PD times were calculated for the cells at
passage 2. Cells isolated from the inguinal, flank,
omental and neck regions all showed similar PD times
whereas ASCs extracted from pericardiac tissue had a
significantly longer PD time (Fig. 4). Treatment with
bFGF reduced PD time for all the cultures except the
cells isolated from the omentum (Fig. 4). In contrast,
application of PDGF only reduced the PD time of
ASCs taken from the neck region (Fig. 4).
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Discussion
Nerve injury is very common and often affecting
young patients (mean age 30). In spite of advanced
treatment options involving microsurgery, almost all
patients are left with lifelong disabilities involving
loss of sensation and motor function (Lundborg 2000).
New tissue-engineering approaches might facilitate
the process of nerve repair and regeneration and would
certainly represent a tremendous medical break-
through. An advantageous approach for clinical
practice would be to harvest ASCs and immediately
Fig. 1 Different harvest locations with harvest tissue aside A neck, B flank, C inguinal, D pericardiac, E omentum
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give them back to the patient within the same
operation, the so called ‘‘one-step surgical procedure’’
(Helder et al. 2007).
As ASCs from different origins might have differ-
ent utility for the treatment of nerve injury, we
investigated whether cell proliferation differs among
different origins. For this purpose we used a model
system which keeps other environmental factors
stable, including age and donor gender.
Our results showed that pericardiac ASCs grew
significantly slower than the cells isolated from other
regions. The growth rate was enhanced for all types
except omental ASCs with bFGF. PDGF had minimal
effect on ASCs proliferation rate, only enhancing the
Fig. 2 Representative
immunofluorescent staining
of ASCs from different
harvest locations. The cells
were stained with nestin
(red) and S100 (green),
respectively. The nuclei are
stained with DAPI (40-6-
diamidino-2-phenylindole,
blue). Scale bar 100 lm.
(Color figure online)
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growth of ASCs from the neck region. This goes in line
with our immunohistochemical analysis where high
levels of S100 expression were found in ASCs from
the flank and neck regions. Furthermore, a basal
expression of nestin but no expression of GFAP was
found. This is consistent with the literature where
undifferentiated ASCs have been found to constitu-
tively express neural specific proteins (Deng et al.
Fig. 3 Proliferation rate of ASC from different origins (ing
inguinal, flk flank, peri pericardiac, om omental, and neck) with
GM alone (a), or addition of bFGF (b) and PDGF (c). *p \ 0.05,
**p \ 0.01, ***p \ 0.001 significantly different from respec-
tive samples at 24 h and #p \ 0.05 significantly different at 96 h
compared with ASCs from inguinal, flank or neck regions
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2006; Kaewkhaw et al. 2011; Lattanzi et al. 2011). It is
suggested that nestin expression is an essential
prerequisite for MSCs to progress toward a neural
lineage (Wislet-Gendebien et al. 2003).
Controversy exists about the capacity of MSCs to
transdifferentiate into lineages derived from the neu-
roectoderm (Phinney and Prockop 2007). New find-
ings suggest that the ability of MSCs to alter the tissue
microenvironment via secretion of soluble factors may
contribute more significantly than their capacity for
transdifferentiation in tissue repair (Phinney and
Prockop 2007). In addition, stromal cells have been
shown to express neurotrophic receptor proteins
(Labouyrie et al. 1999). Thus, our results could be
attributed to the fact that the various populations of
ASCs could express different levels of basic FGF
receptor or contain CD271-expressing cells, which
have been shown to co-express CD140b (platelet-
derived growth factor receptor b (Buhring et al. 2007).
In this study we decided to use bFGF and PDGF as
they are potent mitogens for glial cells and have a
potential effect on nerve repair (Lutton et al. 2012;
Yun et al. 2010). Fibroblast growth factors (FGFs)
have shown potential effects on the repair and
regeneration of a wide spectrum of tissues, including
skin, blood vessel, muscle (Tassi et al. 2011), de novo
adipogenesis (Tabata et al. 2000), tendon/ligament
(Hankemeier et al. 2005), cartilage (Martin et al.
2001), bone (Kimura et al. 2008), tooth (Kitamura
et al. 2011), and nerve tissues (Yun et al. 2010).
PDGF was first identified as a factor in platelets
which allowed the growth of fibroblasts in vitro
(Kohler and Lipton 1974). Further characterization of
this factor demonstrated that it is a potent mitogen for
all cells of mesenchymal origin, including vascular
smooth muscle cells and glial cells (Ross et al. 1986).
PDGF is, as FGF, an angiogenic growth factor that
accelerates capillary formation (Sato et al. 1993).
Adipose tissue growth seems to be regulated through
angiogenesis (Hausman and Richardson 2004) and
PDGF itself stimulates pre-adipocyte proliferation
(Hauner et al. 1995). Furthermore, it has been reported
that a mixture of glial growth factors (containing
heregulin, forskolin, PDGF and bFGF) can induce
ASCs into cells which are spindle-like in shape and
express GFAP, S100 and p75, similar to genuine
Schwann cells (SCs) (Jiang et al. 2008; Kingham et al.
2007). In response to forskolin, cultured primary SCs
increase cAMP and hence myelin protein p0 can be
induced (Morgan et al. 1991). Expression of p0 in
response to forskolin is a very important feature of
SCs, which indicates that SCs may have myelin-
forming ability (Morgan et al. 1991). In addition,
cAMP elevation is reported to enhance the respon-
siveness of cells to trophic factors (Meyer-Franke et al.
1998). Different mitogenic factors, amongst others
bFGF and PDGF could have a synergistic effect in
enhancement of these factors to MSCs (Dezawa et al.
2001).
Finally, our study has some limitations since the
cells we investigated were isolated from experimental
animals. Thus, due to potential differences between
human and rodent MSCs direct comparisons cannot be
drawn. Nevertheless, our results have identified that
ASCs isolated from the neck region proliferate rapidly
in response to bFGF and show enhanced growth with
Fig. 4 Population doubling
(PD) times for ASCs
isolated from the different
harvest locations and
cultured in growth medium
alone (GM) or in the
presence of bFGF or PDGF.
*p \ 0.05, **p \ 0.01
significantly different from
pericardiac ASCs. #p \ 0.05
significantly decreased PD
time in the presence of bFGF
Cytotechnology (2013) 65:437–445 443
123
PDGF treatment. Future studies will utilise these cells
in experimental in vivo models to assess their func-
tional effects within the injured nervous system.
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